Osman I - Search Results

1

Novel mutations of epidermal growth factor receptor in localized prostate cancer.

Douglas DA, Zhong H, Ro JY, Oddoux C, Berger AD, Pincus MR, Satagopan JM, Gerald WL, Scher HI, Lee P, Osman I. Douglas DA, et al. Among authors: osman i. Front Biosci. 2006 Sep 1;11:2518-25. doi: 10.2741/1986. Front Biosci. 2006. PMID: 16720329

2

Chromosome 16 in primary prostate cancer: a microsatellite analysis.

Osman I, Scher H, Dalbagni G, Reuter V, Zhang ZF, Cordon-Cardo C. Osman I, et al. Int J Cancer. 1997 May 16;71(4):580-4. doi: 10.1002/(sici)1097-0215(19970516)71:4<580::aid-ijc12>3.0.co;2-g. Int J Cancer. 1997. PMID: 9178811

3

Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.

Wu RL, Osman I, Wu XR, Lu ML, Zhang ZF, Liang FX, Hamza R, Scher H, Cordon-Cardo C, Sun TT. Wu RL, et al. Among authors: osman i. Cancer Res. 1998 Mar 15;58(6):1291-7. Cancer Res. 1998. PMID: 9515818

4

Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.

Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI. Cordon-Cardo C, et al. Among authors: osman i. J Natl Cancer Inst. 1998 Sep 2;90(17):1284-91. doi: 10.1093/jnci/90.17.1284. J Natl Cancer Inst. 1998. PMID: 9731735

5

Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.

Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C. Osman I, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2247-51. Clin Cancer Res. 1997. PMID: 9815621

6

Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.

Osman I, Scher HI, Zhang ZF, Pellicer I, Hamza R, Eissa S, Khaled H, Cordon-Cardo C. Osman I, et al. Clin Cancer Res. 1997 Apr;3(4):531-6. Clin Cancer Res. 1997. PMID: 9815716

7

Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.

Lee CT, Capodieci P, Osman I, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C. Lee CT, et al. Among authors: osman i. Clin Cancer Res. 1999 May;5(5):977-83. Clin Cancer Res. 1999. PMID: 10353729

8

Inactivation of the p53 pathway in prostate cancer: impact on tumor progression.

Osman I, Drobnjak M, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C. Osman I, et al. Clin Cancer Res. 1999 Aug;5(8):2082-8. Clin Cancer Res. 1999. PMID: 10473090

9

Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.

Ghossein RA, Osman I, Bhattacharya S, Ferrara J, Fazzari M, Cordon-Cardo C, Scher HI. Ghossein RA, et al. Among authors: osman i. Diagn Mol Pathol. 1999 Jun;8(2):59-65. doi: 10.1097/00019606-199906000-00001. Diagn Mol Pathol. 1999. PMID: 10475379

10

The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer.

Kelly WK, Osman I, Reuter VE, Curley T, Heston WD, Nanus DM, Scher HI. Kelly WK, et al. Among authors: osman i. Clin Cancer Res. 2000 Mar;6(3):838-46. Clin Cancer Res. 2000. PMID: 10741705 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters